RE: Eton rests8 Feb 2021 19:20
Good call Balanced. I sincerely hope that is the case, regarding them needing the $45 million to fund upfront payments for Chronocort distribution, amongst other things. It would obviously make sense, for adults to move on to Chronocort and if this is the reason (or even part of it) for their neurology sale, it would indicate high confidence levels from them in Chronocort being granted approval. I really think this bodes well for us here, especially as their share price is ticking up nicely over time and with them expanding Alkindi territory into Canada, as Andypa pointed out. We will get there too...all the foundations are being laid down nicely here, with new deals being struck for new sales territories constantly.
Oh and I agree with Chester about their results being more than likely due around the 5th March. I’d taken it as today’s date as went from someone mentioning it on this bb previously, but after double checking Eton’s date for last year, he is correct.